How to use Personalized Biometrics Support to Run Better Clinical Trials
Monday, 18 October 2021

It is World Statistics Day on 20th October, and we would like to highlight how effective biometric support is rising as a top strategic priority for running efficient clinical trials.

Continue Reading
What Makes us RISE to Support Patient Centric Oncology Clinical Trials? Supporting Breast Cancer Awareness Month
Monday, 11 October 2021

October is breast cancer awareness month, and Navitas Life Sciences continues to RISE consistently to the unique needs of oncology patients.

Continue Reading
How to be Data Smart with R Programming and Accelerate Clinical Trial Efficiency
Monday, 04 October 2021

Technology led Navitas Life Sciences amped-up digital initiatives, especially during the pandemic, with the inclusion of innovation, creating fertile

Continue Reading
How to Run Successful Clinical Trials During the Pandemic and Beyond
Tuesday, 28 September 2021

There was a considerable change in the clinical trial landscape at the onset of the global epidemic, with the initiation of multiple COVID-19 clinical trials

Continue Reading
How Our PV Networks Provide Vital Insights Towards Ensuring Patient Safety
Thursday, 23 September 2021

Navitas Life Sciences joins the National Coordination Centre, Indian Pharmacopoeia Commission in celebrating National Pharmacovigilance week 17-23rd September 2021.

Continue Reading
Gain Cutting Edge Perspective from Experts on Clinical Trial Strategy and Management
Monday, 13 September 2021

Here is how Navitas Life Sciences Defines Key Aspects on Building a resilient Future

Continue Reading
How Navitas Life Sciences helps Leading Pharma Unlock the Value of their Clinical Data
Monday, 06 September 2021

Dr. Manish Harsh, Vice President, Clinical data Services provides key insights about the impact of technology on efficient clinical data management

Continue Reading
Why is it Advantageous to outsource QPPV to Navitas Life Sciences?
Monday, 30 August 2021

A Market Authorization Holder (MAH) appoints a Qualified Person responsible for Pharmacovigilance (QPPV) to market drug products in the European Union (EU)...

Continue Reading
How pharmaREADY® is Driving Transformation in Regulatory Affairs
Monday, 23 August 2021

Regulatory Affairs play a pivotal role in bringing new drug products to the market swiftly. However, it is often perceived

Continue Reading
Why leading pharma companies need our qualityREADY Analytics
Monday, 16 August 2021

In the everchanging clinical trial landscape, a sustainable quality management system is imperative. The Pharmaceutical Quality for the 21st Century

Continue Reading
Page 1 of 5